| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Idiotypes | 47 | 1990 | 200 | 1.600 |
Why?
|
| Hybridomas | 36 | 1995 | 442 | 1.470 |
Why?
|
| Nitrophenols | 43 | 2001 | 169 | 1.340 |
Why?
|
| T-Lymphocytes, Regulatory | 61 | 1995 | 3112 | 1.310 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 15 | 2009 | 820 | 1.260 |
Why?
|
| Astrocytes | 13 | 2006 | 1353 | 1.220 |
Why?
|
| T-Lymphocytes | 107 | 2006 | 10260 | 1.200 |
Why?
|
| H-2 Antigens | 45 | 1990 | 359 | 1.170 |
Why?
|
| Haptens | 31 | 2001 | 163 | 1.160 |
Why?
|
| Chemokine CCL5 | 11 | 2003 | 213 | 1.140 |
Why?
|
| Chemokines | 12 | 2004 | 959 | 1.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 23 | 2009 | 975 | 1.040 |
Why?
|
| Lymphocyte Activation | 57 | 2001 | 5503 | 0.990 |
Why?
|
| Suppressor Factors, Immunologic | 30 | 1995 | 68 | 0.980 |
Why?
|
| Metalloendopeptidases | 2 | 2017 | 386 | 0.980 |
Why?
|
| Chemokines, CC | 18 | 2006 | 285 | 0.950 |
Why?
|
| Hypersensitivity, Delayed | 32 | 2001 | 490 | 0.910 |
Why?
|
| Ubiquitination | 7 | 2020 | 1000 | 0.880 |
Why?
|
| Mice, Inbred BALB C | 79 | 2009 | 6215 | 0.870 |
Why?
|
| Receptors, Chemokine | 11 | 2006 | 651 | 0.850 |
Why?
|
| Lymphokines | 29 | 1992 | 905 | 0.840 |
Why?
|
| Histocompatibility Antigens Class II | 42 | 1999 | 1441 | 0.830 |
Why?
|
| Cytokines | 27 | 2017 | 7426 | 0.830 |
Why?
|
| Antigen-Presenting Cells | 26 | 2002 | 960 | 0.820 |
Why?
|
| Influenza A virus | 6 | 2024 | 455 | 0.770 |
Why?
|
| Mice | 285 | 2024 | 81839 | 0.770 |
Why?
|
| Chemotactic Factors | 9 | 2001 | 196 | 0.750 |
Why?
|
| Chemokines, CXC | 10 | 2004 | 417 | 0.740 |
Why?
|
| Epitopes | 68 | 2000 | 2523 | 0.710 |
Why?
|
| Mice, Inbred Strains | 62 | 2005 | 1769 | 0.710 |
Why?
|
| Chemokine CCL2 | 13 | 2003 | 602 | 0.640 |
Why?
|
| NF-kappa B | 6 | 2020 | 2495 | 0.630 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2020 | 1897 | 0.600 |
Why?
|
| Influenza, Human | 5 | 2024 | 1542 | 0.570 |
Why?
|
| RNA-Binding Proteins | 3 | 2017 | 1883 | 0.560 |
Why?
|
| Animals | 303 | 2024 | 168800 | 0.560 |
Why?
|
| Interferon-gamma | 20 | 2017 | 3159 | 0.540 |
Why?
|
| Phenylacetates | 39 | 1995 | 112 | 0.520 |
Why?
|
| Histocompatibility Antigens | 45 | 1989 | 479 | 0.520 |
Why?
|
| Antigens, Surface | 22 | 2003 | 1616 | 0.520 |
Why?
|
| Macrophages | 29 | 2001 | 5776 | 0.510 |
Why?
|
| Genes | 31 | 1996 | 1824 | 0.500 |
Why?
|
| Membrane Proteins | 7 | 2017 | 7850 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2013 | 4342 | 0.480 |
Why?
|
| Receptors, Antigen, T-Cell | 21 | 2007 | 2570 | 0.470 |
Why?
|
| Antibody Formation | 38 | 1991 | 1392 | 0.470 |
Why?
|
| Peptides | 49 | 2009 | 4338 | 0.460 |
Why?
|
| Endosomes | 1 | 2017 | 521 | 0.460 |
Why?
|
| Antigens | 32 | 2001 | 1437 | 0.450 |
Why?
|
| Immunity, Innate | 7 | 2021 | 3079 | 0.440 |
Why?
|
| Glomerular Mesangium | 3 | 1999 | 97 | 0.440 |
Why?
|
| Receptors, HIV | 4 | 1998 | 159 | 0.440 |
Why?
|
| Immune Tolerance | 22 | 1993 | 2324 | 0.430 |
Why?
|
| Protein Interaction Mapping | 3 | 2017 | 619 | 0.420 |
Why?
|
| Virus Diseases | 3 | 2017 | 720 | 0.420 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 303 | 0.420 |
Why?
|
| Genes, MHC Class II | 23 | 1987 | 433 | 0.410 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2013 | 196 | 0.410 |
Why?
|
| B-Lymphocytes | 38 | 2000 | 4782 | 0.400 |
Why?
|
| Clone Cells | 27 | 2009 | 1671 | 0.390 |
Why?
|
| HEK293 Cells | 8 | 2024 | 4263 | 0.390 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2009 | 56 | 0.380 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 11 | 1992 | 893 | 0.380 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1468 | 0.380 |
Why?
|
| RNA Viruses | 1 | 2012 | 110 | 0.370 |
Why?
|
| Signal Transduction | 11 | 2020 | 23605 | 0.360 |
Why?
|
| Viral Proteins | 3 | 2024 | 1801 | 0.350 |
Why?
|
| I-kappa B Kinase | 2 | 2009 | 250 | 0.350 |
Why?
|
| Lysine | 18 | 2009 | 994 | 0.340 |
Why?
|
| Autoantigens | 1 | 2014 | 886 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 84 | 2024 | 22341 | 0.330 |
Why?
|
| Immunity, Cellular | 17 | 2001 | 1557 | 0.330 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2001 | 1656 | 0.320 |
Why?
|
| Gene Expression Regulation | 10 | 2017 | 11906 | 0.320 |
Why?
|
| Spleen | 45 | 2001 | 2294 | 0.320 |
Why?
|
| Mice, Inbred C3H | 31 | 1998 | 915 | 0.320 |
Why?
|
| Proteomics | 5 | 2020 | 3907 | 0.320 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 12 | 1995 | 812 | 0.320 |
Why?
|
| Glutamates | 32 | 1980 | 384 | 0.310 |
Why?
|
| Antibody Specificity | 31 | 1998 | 1061 | 0.310 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2009 | 202 | 0.310 |
Why?
|
| Polyubiquitin | 1 | 2009 | 68 | 0.310 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2009 | 229 | 0.310 |
Why?
|
| Immunomodulation | 1 | 2012 | 548 | 0.310 |
Why?
|
| Cell Line | 29 | 2020 | 15546 | 0.300 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2008 | 17 | 0.300 |
Why?
|
| Cell Membrane | 8 | 2017 | 3635 | 0.300 |
Why?
|
| Myelin Proteolipid Protein | 6 | 2000 | 107 | 0.300 |
Why?
|
| MicroRNAs | 2 | 2014 | 3787 | 0.290 |
Why?
|
| Protein Kinase C | 2 | 2009 | 1205 | 0.290 |
Why?
|
| Antibodies | 21 | 2003 | 2415 | 0.290 |
Why?
|
| Receptors, Cytokine | 4 | 2006 | 257 | 0.290 |
Why?
|
| Cells, Cultured | 30 | 2011 | 18967 | 0.280 |
Why?
|
| Interferon Type I | 1 | 2011 | 568 | 0.280 |
Why?
|
| Virus Internalization | 2 | 2024 | 503 | 0.280 |
Why?
|
| Major Histocompatibility Complex | 19 | 1992 | 880 | 0.280 |
Why?
|
| Protein Binding | 10 | 2020 | 9301 | 0.280 |
Why?
|
| T-Box Domain Proteins | 1 | 2009 | 470 | 0.270 |
Why?
|
| Cell Separation | 5 | 2015 | 1718 | 0.270 |
Why?
|
| Chemotaxis | 7 | 2001 | 596 | 0.260 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2008 | 252 | 0.260 |
Why?
|
| Molecular Sequence Data | 27 | 2009 | 17597 | 0.260 |
Why?
|
| Chromosome Mapping | 25 | 1998 | 4617 | 0.260 |
Why?
|
| Interleukin-17 | 2 | 2009 | 922 | 0.260 |
Why?
|
| Cross Reactions | 24 | 1988 | 825 | 0.260 |
Why?
|
| Immunoglobulin lambda-Chains | 6 | 1989 | 84 | 0.260 |
Why?
|
| RNA, Messenger | 20 | 2006 | 12775 | 0.250 |
Why?
|
| Binding Sites, Antibody | 20 | 1986 | 340 | 0.250 |
Why?
|
| Receptors, CCR8 | 9 | 2006 | 28 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 13 | 1997 | 1346 | 0.240 |
Why?
|
| Chemokine CCL1 | 10 | 2006 | 22 | 0.240 |
Why?
|
| Immunoglobulin Light Chains | 6 | 1986 | 289 | 0.240 |
Why?
|
| Receptors, Interleukin-8B | 3 | 2000 | 58 | 0.240 |
Why?
|
| Immunologic Techniques | 7 | 2001 | 212 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2879 | 0.230 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 415 | 0.230 |
Why?
|
| Enzyme Activation | 5 | 2012 | 3584 | 0.230 |
Why?
|
| Glycoproteins | 3 | 2024 | 2196 | 0.230 |
Why?
|
| Chemokine CXCL2 | 5 | 2003 | 105 | 0.230 |
Why?
|
| Rabies virus | 1 | 2024 | 37 | 0.230 |
Why?
|
| Immunoglobulin Heavy Chains | 13 | 1988 | 647 | 0.230 |
Why?
|
| Receptors, CXCR4 | 5 | 2002 | 729 | 0.230 |
Why?
|
| Cloning, Molecular | 12 | 2004 | 4163 | 0.230 |
Why?
|
| Mice, Inbred DBA | 29 | 1995 | 624 | 0.220 |
Why?
|
| RNA Interference | 2 | 2017 | 2828 | 0.220 |
Why?
|
| Antigen Presentation | 5 | 2004 | 1250 | 0.220 |
Why?
|
| Chemokine CXCL1 | 5 | 2004 | 102 | 0.220 |
Why?
|
| Cricetinae | 9 | 1998 | 2413 | 0.220 |
Why?
|
| Immunoglobulin Allotypes | 7 | 1984 | 52 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 22 | 2006 | 9237 | 0.220 |
Why?
|
| Immune Sera | 29 | 1982 | 601 | 0.220 |
Why?
|
| Chemokine CCL4 | 6 | 2003 | 124 | 0.220 |
Why?
|
| Macrophage Inflammatory Proteins | 6 | 2003 | 121 | 0.210 |
Why?
|
| Lymphocyte Cooperation | 5 | 1987 | 112 | 0.210 |
Why?
|
| Cat Diseases | 1 | 2002 | 32 | 0.210 |
Why?
|
| Isoantibodies | 22 | 1987 | 681 | 0.210 |
Why?
|
| Mice, Inbred A | 21 | 1984 | 244 | 0.210 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2024 | 209 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2003 | 205 | 0.200 |
Why?
|
| Neutrophils | 4 | 2015 | 3771 | 0.200 |
Why?
|
| Amino Acid Sequence | 20 | 2009 | 13400 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2011 | 3801 | 0.190 |
Why?
|
| Hybrid Cells | 10 | 1990 | 420 | 0.190 |
Why?
|
| Biological Factors | 4 | 1990 | 155 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2002 | 122 | 0.190 |
Why?
|
| Monokines | 3 | 2003 | 71 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 203 | 0.190 |
Why?
|
| Guinea Pigs | 19 | 1998 | 1300 | 0.190 |
Why?
|
| Thymus Gland | 8 | 1997 | 1259 | 0.190 |
Why?
|
| Antigens, Differentiation | 5 | 2017 | 920 | 0.180 |
Why?
|
| Chemokines, CX3C | 1 | 2000 | 12 | 0.180 |
Why?
|
| Transfection | 7 | 2015 | 5739 | 0.180 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 484 | 0.180 |
Why?
|
| Antibody-Producing Cells | 10 | 1985 | 139 | 0.170 |
Why?
|
| Histocompatibility | 14 | 1978 | 327 | 0.170 |
Why?
|
| Pertussis Toxin | 4 | 2003 | 174 | 0.170 |
Why?
|
| Binding, Competitive | 11 | 1996 | 1140 | 0.170 |
Why?
|
| Mice, Knockout | 11 | 2024 | 14456 | 0.170 |
Why?
|
| Mice, Nude | 7 | 1994 | 3610 | 0.170 |
Why?
|
| Species Specificity | 25 | 2000 | 2406 | 0.160 |
Why?
|
| Lymphocyte Culture Test, Mixed | 7 | 1986 | 511 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2020 | 12130 | 0.160 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 243 | 0.160 |
Why?
|
| Genetic Complementation Test | 7 | 2017 | 556 | 0.160 |
Why?
|
| Virulence Factors, Bordetella | 4 | 2002 | 152 | 0.160 |
Why?
|
| Recombinant Proteins | 12 | 2002 | 6493 | 0.160 |
Why?
|
| Virus Replication | 3 | 2024 | 2458 | 0.160 |
Why?
|
| Interleukin-1 | 8 | 1996 | 1242 | 0.150 |
Why?
|
| Neuroglia | 2 | 1995 | 963 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 1998 | 2815 | 0.150 |
Why?
|
| Phosphorylation | 5 | 2009 | 8292 | 0.150 |
Why?
|
| Antibodies, Anti-Idiotypic | 7 | 1989 | 340 | 0.150 |
Why?
|
| Macrophage Activation | 4 | 1994 | 553 | 0.150 |
Why?
|
| Isoantigens | 14 | 1987 | 562 | 0.150 |
Why?
|
| Blotting, Northern | 8 | 1995 | 1546 | 0.150 |
Why?
|
| Myelin Proteins | 3 | 1993 | 212 | 0.150 |
Why?
|
| Polymers | 22 | 1992 | 1622 | 0.150 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 154 | 0.150 |
Why?
|
| Hemolytic Plaque Technique | 14 | 1995 | 59 | 0.140 |
Why?
|
| Immunization | 18 | 1999 | 1218 | 0.140 |
Why?
|
| Interleukin-6 | 4 | 1991 | 3227 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1991 | 822 | 0.140 |
Why?
|
| Genetic Linkage | 21 | 1990 | 2342 | 0.140 |
Why?
|
| Immunization, Passive | 14 | 1995 | 616 | 0.140 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 7600 | 0.140 |
Why?
|
| Plakophilins | 1 | 2017 | 32 | 0.140 |
Why?
|
| Antilymphocyte Serum | 9 | 1984 | 492 | 0.140 |
Why?
|
| Polyglutamic Acid | 4 | 1987 | 46 | 0.140 |
Why?
|
| Microglia | 4 | 2000 | 1371 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2020 | 760 | 0.130 |
Why?
|
| Endothelium, Lymphatic | 3 | 2001 | 63 | 0.130 |
Why?
|
| CHO Cells | 5 | 1996 | 1373 | 0.130 |
Why?
|
| Tyrosine | 19 | 1980 | 1427 | 0.130 |
Why?
|
| Chemokine CCL3 | 3 | 2001 | 84 | 0.130 |
Why?
|
| Polylysine | 3 | 1987 | 130 | 0.130 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 1995 | 5 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2864 | 0.130 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1995 | 94 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.130 |
Why?
|
| Interleukin-3 | 4 | 1995 | 423 | 0.130 |
Why?
|
| Antigen-Antibody Reactions | 15 | 1989 | 340 | 0.120 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 257 | 0.120 |
Why?
|
| Immunoglobulin Variable Region | 7 | 1984 | 419 | 0.120 |
Why?
|
| Dose-Response Relationship, Immunologic | 14 | 2003 | 355 | 0.120 |
Why?
|
| Mice, Inbred AKR | 11 | 2000 | 103 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 9527 | 0.120 |
Why?
|
| Gene Amplification | 1 | 1999 | 1088 | 0.120 |
Why?
|
| Antigens, Ly | 9 | 1992 | 297 | 0.120 |
Why?
|
| Alanine | 19 | 1980 | 613 | 0.120 |
Why?
|
| Intramolecular Transferases | 1 | 2014 | 14 | 0.120 |
Why?
|
| Dinitrobenzenes | 5 | 1989 | 37 | 0.120 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2014 | 52 | 0.110 |
Why?
|
| Demyelinating Diseases | 2 | 1998 | 355 | 0.110 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.110 |
Why?
|
| Cricetulus | 4 | 1998 | 807 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 1998 | 1245 | 0.110 |
Why?
|
| Dendritic Cells | 3 | 2001 | 2747 | 0.110 |
Why?
|
| Flow Cytometry | 7 | 2007 | 5881 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 1995 | 1801 | 0.110 |
Why?
|
| Chemokine CCL11 | 3 | 2002 | 127 | 0.110 |
Why?
|
| Inflammation | 8 | 2007 | 10860 | 0.110 |
Why?
|
| Cell Adhesion | 8 | 1996 | 3089 | 0.100 |
Why?
|
| Phenotype | 24 | 2004 | 16716 | 0.100 |
Why?
|
| Cyclophosphamide | 15 | 1987 | 2232 | 0.100 |
Why?
|
| Kinetics | 13 | 1996 | 6273 | 0.100 |
Why?
|
| Nitrobenzenes | 7 | 1987 | 64 | 0.100 |
Why?
|
| Minor Lymphocyte Stimulatory Antigens | 5 | 1991 | 10 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 1998 | 1103 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 874 | 0.100 |
Why?
|
| Gene Expression | 8 | 2000 | 7582 | 0.100 |
Why?
|
| DNA | 6 | 2021 | 7193 | 0.100 |
Why?
|
| Arabidopsis Proteins | 1 | 2014 | 261 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 800 | 0.100 |
Why?
|
| Interleukin-12 | 2 | 2007 | 581 | 0.100 |
Why?
|
| RNA Stability | 1 | 2014 | 319 | 0.100 |
Why?
|
| Dogs | 4 | 2024 | 3824 | 0.100 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2003 | 187 | 0.100 |
Why?
|
| Ubiquitins | 1 | 2013 | 365 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2015 | 1644 | 0.100 |
Why?
|
| H-Y Antigen | 2 | 1983 | 42 | 0.100 |
Why?
|
| Cell Division | 5 | 2003 | 4466 | 0.100 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1990 | 32 | 0.090 |
Why?
|
| Growth Substances | 3 | 2001 | 758 | 0.090 |
Why?
|
| Immunocompetence | 1 | 1991 | 138 | 0.090 |
Why?
|
| gamma-Globulins | 8 | 1981 | 119 | 0.090 |
Why?
|
| Chromatography, Affinity | 2 | 2008 | 521 | 0.090 |
Why?
|
| Immunoglobulin E | 5 | 1989 | 1480 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 4565 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 1995 | 4408 | 0.090 |
Why?
|
| Ascitic Fluid | 3 | 2015 | 189 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1494 | 0.080 |
Why?
|
| Dermatitis, Contact | 4 | 1984 | 134 | 0.080 |
Why?
|
| Neoplasms, Experimental | 9 | 1987 | 1227 | 0.080 |
Why?
|
| Rabbits | 16 | 1983 | 4730 | 0.080 |
Why?
|
| Peptide Fragments | 6 | 2000 | 5126 | 0.080 |
Why?
|
| Cell Movement | 7 | 2005 | 5196 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 3424 | 0.080 |
Why?
|
| Trinitrobenzenes | 8 | 1988 | 45 | 0.080 |
Why?
|
| Oligopeptides | 5 | 1981 | 1195 | 0.080 |
Why?
|
| Prostatic Secretory Proteins | 1 | 1989 | 24 | 0.080 |
Why?
|
| Receptors, Immunologic | 3 | 1987 | 1416 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 11035 | 0.080 |
Why?
|
| Ligands | 4 | 2003 | 3274 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2014 | 3073 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2009 | 62 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1998 | 2743 | 0.080 |
Why?
|
| Phenylalanine | 8 | 1980 | 367 | 0.080 |
Why?
|
| Central Nervous System | 2 | 2007 | 1343 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 4 | 2000 | 379 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 4 | 1986 | 282 | 0.080 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 317 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 2675 | 0.080 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2009 | 151 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1988 | 103 | 0.080 |
Why?
|
| Base Sequence | 9 | 2002 | 12405 | 0.080 |
Why?
|
| Humans | 41 | 2024 | 766117 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 1988 | 236 | 0.070 |
Why?
|
| Viruses | 2 | 2011 | 371 | 0.070 |
Why?
|
| Leukocytes | 8 | 1998 | 2030 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2195 | 0.070 |
Why?
|
| Ficoll | 3 | 2001 | 39 | 0.070 |
Why?
|
| Absorption | 8 | 1981 | 242 | 0.070 |
Why?
|
| Multigene Family | 2 | 1990 | 1081 | 0.070 |
Why?
|
| Immunoglobulin M | 6 | 1989 | 1527 | 0.070 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2007 | 110 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 1996 | 1890 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2009 | 9540 | 0.070 |
Why?
|
| Exons | 4 | 2004 | 2393 | 0.070 |
Why?
|
| Leukemia P388 | 5 | 1988 | 14 | 0.070 |
Why?
|
| Chemokine CXCL12 | 3 | 2000 | 455 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 439 | 0.070 |
Why?
|
| Cell Fusion | 2 | 1985 | 294 | 0.070 |
Why?
|
| Receptors, Antigen, B-Cell | 5 | 1987 | 545 | 0.070 |
Why?
|
| Animal Population Groups | 1 | 1986 | 12 | 0.070 |
Why?
|
| Cold Ischemia | 1 | 2006 | 72 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 1885 | 0.070 |
Why?
|
| Th1 Cells | 2 | 2002 | 1041 | 0.070 |
Why?
|
| Crosses, Genetic | 5 | 1998 | 752 | 0.070 |
Why?
|
| Female | 59 | 2003 | 396233 | 0.060 |
Why?
|
| Lymph Nodes | 11 | 2002 | 3456 | 0.060 |
Why?
|
| Myeloma Proteins | 1 | 1986 | 71 | 0.060 |
Why?
|
| Animals, Wild | 1 | 1986 | 78 | 0.060 |
Why?
|
| Mice, Inbred CBA | 7 | 1995 | 439 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 1989 | 537 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 252 | 0.060 |
Why?
|
| Leukemia, Experimental | 3 | 1984 | 224 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 415 | 0.060 |
Why?
|
| Glomerulonephritis | 2 | 1997 | 331 | 0.060 |
Why?
|
| Protein Transport | 2 | 2020 | 1939 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2003 | 1814 | 0.060 |
Why?
|
| Rats | 18 | 2000 | 23717 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 1989 | 992 | 0.060 |
Why?
|
| Autoimmune Diseases | 3 | 1995 | 2249 | 0.060 |
Why?
|
| Plasmacytoma | 1 | 1986 | 171 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6363 | 0.060 |
Why?
|
| Cell Differentiation | 8 | 2007 | 11642 | 0.060 |
Why?
|
| Cell Communication | 2 | 1984 | 1660 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 651 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1995 | 890 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 327 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 231 | 0.060 |
Why?
|
| Bone Marrow Cells | 4 | 2015 | 2411 | 0.060 |
Why?
|
| Immunophenotyping | 1 | 2009 | 1865 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2024 | 75 | 0.060 |
Why?
|
| Rabies | 1 | 2024 | 56 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 1989 | 1077 | 0.060 |
Why?
|
| Recombination, Genetic | 7 | 1982 | 1525 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1998 | 1984 | 0.060 |
Why?
|
| Receptors, CXCR3 | 2 | 2006 | 240 | 0.060 |
Why?
|
| Keratitis, Herpetic | 2 | 1995 | 76 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2004 | 265 | 0.060 |
Why?
|
| Nuclease Protection Assays | 1 | 2003 | 14 | 0.060 |
Why?
|
| Gene Library | 1 | 2006 | 1066 | 0.060 |
Why?
|
| Receptors, CCR2 | 3 | 2003 | 215 | 0.050 |
Why?
|
| Lipopolysaccharides | 5 | 1995 | 2213 | 0.050 |
Why?
|
| Glycosylation | 3 | 1993 | 1099 | 0.050 |
Why?
|
| Macaca | 5 | 1976 | 413 | 0.050 |
Why?
|
| Autoimmunity | 1 | 1991 | 1354 | 0.050 |
Why?
|
| Thyroid Gland | 2 | 1987 | 1168 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2006 | 400 | 0.050 |
Why?
|
| Schistosomiasis | 1 | 1983 | 65 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 1997 | 945 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 1998 | 5758 | 0.050 |
Why?
|
| Cycloheximide | 2 | 2000 | 339 | 0.050 |
Why?
|
| Interleukin-8 | 2 | 1996 | 699 | 0.050 |
Why?
|
| Dinitrophenols | 6 | 1975 | 56 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6102 | 0.050 |
Why?
|
| Homozygote | 2 | 2004 | 1774 | 0.050 |
Why?
|
| Interleukin-4 | 4 | 1998 | 1149 | 0.050 |
Why?
|
| Polyomavirus | 2 | 1995 | 236 | 0.050 |
Why?
|
| Mast Cells | 1 | 1989 | 1404 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2006 | 4133 | 0.050 |
Why?
|
| Antigens, CD | 3 | 2003 | 4025 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 2 | 1998 | 107 | 0.050 |
Why?
|
| Diatrizoate | 1 | 2001 | 81 | 0.050 |
Why?
|
| Lung Diseases, Fungal | 1 | 2002 | 123 | 0.050 |
Why?
|
| Cryptococcosis | 1 | 2002 | 99 | 0.050 |
Why?
|
| Cats | 1 | 2002 | 972 | 0.050 |
Why?
|
| Blood Group Antigens | 4 | 1988 | 183 | 0.050 |
Why?
|
| p-Azobenzenearsonate | 3 | 1995 | 41 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 297 | 0.050 |
Why?
|
| Receptors, CCR5 | 2 | 2000 | 491 | 0.050 |
Why?
|
| Sex Chromosomes | 1 | 1981 | 102 | 0.050 |
Why?
|
| DNA, Antisense | 1 | 2000 | 44 | 0.050 |
Why?
|
| Receptors, CCR1 | 1 | 2000 | 30 | 0.050 |
Why?
|
| Carrier Proteins | 4 | 2020 | 4910 | 0.050 |
Why?
|
| DNA Primers | 3 | 2005 | 2824 | 0.050 |
Why?
|
| Granuloma | 1 | 1983 | 329 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.040 |
Why?
|
| Immunity | 2 | 1977 | 1001 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 12 | 1977 | 317 | 0.040 |
Why?
|
| Freund's Adjuvant | 5 | 2001 | 145 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 1996 | 6059 | 0.040 |
Why?
|
| Heterozygote | 2 | 2004 | 2796 | 0.040 |
Why?
|
| Chemokine CX3CL1 | 1 | 2000 | 60 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2000 | 137 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2002 | 1131 | 0.040 |
Why?
|
| Y Chromosome | 1 | 1981 | 205 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 1043 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 641 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1990 | 772 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1990 | 2161 | 0.040 |
Why?
|
| Calcium | 3 | 1998 | 5770 | 0.040 |
Why?
|
| Peyer's Patches | 1 | 2000 | 120 | 0.040 |
Why?
|
| Monocytes | 2 | 2001 | 2591 | 0.040 |
Why?
|
| Male | 49 | 2006 | 363935 | 0.040 |
Why?
|
| Chemokine CXCL11 | 1 | 1998 | 43 | 0.040 |
Why?
|
| Lymphocytes | 8 | 1983 | 2602 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2001 | 528 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3458 | 0.040 |
Why?
|
| Neuritis | 1 | 1998 | 35 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1467 | 0.040 |
Why?
|
| DNA Probes | 2 | 1990 | 541 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2003 | 746 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2000 | 444 | 0.040 |
Why?
|
| U937 Cells | 1 | 1998 | 259 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2898 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2003 | 1186 | 0.040 |
Why?
|
| Cytosol | 1 | 2021 | 885 | 0.040 |
Why?
|
| DNA, Viral | 2 | 1998 | 2200 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 1998 | 364 | 0.040 |
Why?
|
| Oligonucleotides | 2 | 1991 | 561 | 0.040 |
Why?
|
| Receptors, CXCR | 1 | 1998 | 52 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 283 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1241 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3751 | 0.040 |
Why?
|
| Picryl Chloride | 3 | 1990 | 9 | 0.040 |
Why?
|
| Succinimides | 3 | 1982 | 83 | 0.040 |
Why?
|
| Pan troglodytes | 3 | 1972 | 224 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 3 | 1997 | 993 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2008 | 4162 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2677 | 0.030 |
Why?
|
| Calcimycin | 2 | 1987 | 214 | 0.030 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2017 | 72 | 0.030 |
Why?
|
| Antigens, Neoplasm | 7 | 1987 | 1996 | 0.030 |
Why?
|
| Longevity | 1 | 1984 | 1085 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 1994 | 5189 | 0.030 |
Why?
|
| Time Factors | 7 | 2004 | 40108 | 0.030 |
Why?
|
| Homeostasis | 1 | 2008 | 3338 | 0.030 |
Why?
|
| Mutation | 3 | 2012 | 30209 | 0.030 |
Why?
|
| Ovalbumin | 4 | 1998 | 674 | 0.030 |
Why?
|
| Autophagy | 1 | 2024 | 1349 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1996 | 848 | 0.030 |
Why?
|
| Alleles | 8 | 1988 | 6892 | 0.030 |
Why?
|
| Chemokine CCL21 | 3 | 2000 | 49 | 0.030 |
Why?
|
| HIV-1 | 3 | 1998 | 6948 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 858 | 0.030 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 471 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3684 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 975 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1995 | 41 | 0.030 |
Why?
|
| Vaccines, DNA | 1 | 1997 | 279 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1086 | 0.030 |
Why?
|
| Peptide Termination Factors | 1 | 1995 | 56 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2003 | 18321 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1995 | 107 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1995 | 124 | 0.030 |
Why?
|
| Immunoglobulin G | 8 | 1984 | 4556 | 0.030 |
Why?
|
| Muramidase | 1 | 1995 | 163 | 0.030 |
Why?
|
| Superantigens | 1 | 1995 | 124 | 0.030 |
Why?
|
| Interleukin-2 | 5 | 1998 | 1894 | 0.030 |
Why?
|
| Nitrites | 1 | 1995 | 156 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1490 | 0.030 |
Why?
|
| Brain | 3 | 1999 | 27177 | 0.030 |
Why?
|
| Th2 Cells | 2 | 2002 | 1074 | 0.030 |
Why?
|
| Remission Induction | 1 | 2000 | 2413 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2006 | 2417 | 0.030 |
Why?
|
| Genotype | 12 | 1986 | 13028 | 0.030 |
Why?
|
| Viral Envelope Proteins | 2 | 1995 | 639 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 1995 | 113 | 0.030 |
Why?
|
| Rats, Inbred Strains | 3 | 1988 | 2077 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 1995 | 276 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1998 | 651 | 0.030 |
Why?
|
| Neoplasm Transplantation | 3 | 1994 | 2010 | 0.030 |
Why?
|
| Antigens, T-Independent | 2 | 1984 | 20 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1998 | 772 | 0.030 |
Why?
|
| Pollen | 1 | 1974 | 79 | 0.030 |
Why?
|
| Microcirculation | 1 | 1999 | 1282 | 0.030 |
Why?
|
| Formaldehyde | 2 | 1992 | 360 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 1107 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2174 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1994 | 300 | 0.030 |
Why?
|
| Protein Biosynthesis | 4 | 1983 | 2091 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 714 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2000 | 4249 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1524 | 0.030 |
Why?
|
| Mice, Inbred NZB | 2 | 1984 | 57 | 0.030 |
Why?
|
| Immunogenetics | 6 | 1976 | 62 | 0.030 |
Why?
|
| Erythrocytes | 9 | 1982 | 2394 | 0.030 |
Why?
|
| Immunosorbent Techniques | 3 | 1983 | 174 | 0.030 |
Why?
|
| Graft Survival | 1 | 2003 | 3904 | 0.030 |
Why?
|
| Interleukins | 3 | 1992 | 789 | 0.030 |
Why?
|
| Immunization, Secondary | 4 | 1979 | 373 | 0.030 |
Why?
|
| Conalbumin | 1 | 1992 | 5 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10737 | 0.030 |
Why?
|
| Genes, Dominant | 5 | 1979 | 855 | 0.030 |
Why?
|
| Disease Susceptibility | 3 | 1994 | 1790 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2000 | 1811 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1716 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1602 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1995 | 438 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 1999 | 1036 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 1976 | 2341 | 0.020 |
Why?
|
| Antibody Diversity | 2 | 1983 | 72 | 0.020 |
Why?
|
| Receptors, CCR4 | 2 | 2005 | 75 | 0.020 |
Why?
|
| Anterior Chamber | 1 | 1992 | 194 | 0.020 |
Why?
|
| Minor Histocompatibility Loci | 1 | 1991 | 16 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 2 | 1990 | 218 | 0.020 |
Why?
|
| Skin Tests | 4 | 1980 | 630 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2024 | 3068 | 0.020 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1991 | 56 | 0.020 |
Why?
|
| Chickens | 3 | 1979 | 842 | 0.020 |
Why?
|
| Bucladesine | 1 | 1991 | 117 | 0.020 |
Why?
|
| Genetic Code | 3 | 1981 | 139 | 0.020 |
Why?
|
| Alprostadil | 1 | 1991 | 86 | 0.020 |
Why?
|
| Blood Platelets | 5 | 1973 | 2464 | 0.020 |
Why?
|
| Fetus | 1 | 1998 | 1878 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2005 | 3307 | 0.020 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 40 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 1990 | 50 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1972 | 2476 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 3692 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 1318 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2000 | 2060 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
| Haplorhini | 5 | 1976 | 520 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 1997 | 898 | 0.020 |
Why?
|
| Mast-Cell Sarcoma | 4 | 1985 | 46 | 0.020 |
Why?
|
| Haploidy | 3 | 1981 | 128 | 0.020 |
Why?
|
| RNA | 3 | 1989 | 2716 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2002 | 10087 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7237 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 1995 | 743 | 0.020 |
Why?
|
| Immunoglobulins | 4 | 1981 | 853 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1990 | 250 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1991 | 350 | 0.020 |
Why?
|
| Sheep | 5 | 1982 | 1445 | 0.020 |
Why?
|
| Proteins | 2 | 2003 | 5995 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13483 | 0.020 |
Why?
|
| Mice, SCID | 1 | 1994 | 2626 | 0.020 |
Why?
|
| Annexins | 1 | 1989 | 39 | 0.020 |
Why?
|
| Immunologic Memory | 5 | 2000 | 1377 | 0.020 |
Why?
|
| Cell Survival | 3 | 1991 | 5747 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1990 | 417 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 765 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1998 | 1168 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1989 | 339 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 1056 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2004 | 10433 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1988 | 240 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1990 | 425 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3672 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9601 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1986 | 171 | 0.020 |
Why?
|
| Receptors, IgE | 1 | 1989 | 374 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.020 |
Why?
|
| Lymphoma | 3 | 1990 | 1896 | 0.020 |
Why?
|
| Introns | 1 | 1990 | 965 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 626 | 0.020 |
Why?
|
| Passive Cutaneous Anaphylaxis | 3 | 1980 | 31 | 0.020 |
Why?
|
| Suppression, Genetic | 2 | 1977 | 190 | 0.020 |
Why?
|
| Insulin | 3 | 2000 | 6604 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 508 | 0.020 |
Why?
|
| Complement System Proteins | 3 | 1983 | 716 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1999 | 4423 | 0.020 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1990 | 306 | 0.020 |
Why?
|
| Lectins | 1 | 1988 | 487 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 1987 | 1748 | 0.020 |
Why?
|
| Transplantation Immunology | 3 | 1980 | 540 | 0.020 |
Why?
|
| Chemokine CCL22 | 1 | 2005 | 27 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1986 | 1724 | 0.020 |
Why?
|
| Hybrid Vigor | 1 | 1984 | 4 | 0.020 |
Why?
|
| Kidney | 2 | 1997 | 7072 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1992 | 976 | 0.010 |
Why?
|
| Rats, Inbred Lew | 3 | 1985 | 1167 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1986 | 375 | 0.010 |
Why?
|
| Proteinuria | 2 | 1997 | 606 | 0.010 |
Why?
|
| Tritium | 2 | 1975 | 702 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1985 | 396 | 0.010 |
Why?
|
| Hair Color | 1 | 1984 | 131 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1991 | 1611 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2003 | 58 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 393 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9445 | 0.010 |
Why?
|
| Iodine Radioisotopes | 4 | 1975 | 1029 | 0.010 |
Why?
|
| Lung | 2 | 2002 | 10063 | 0.010 |
Why?
|
| Histocompatibility Testing | 3 | 1975 | 726 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 3212 | 0.010 |
Why?
|
| Leukemia L1210 | 3 | 1979 | 44 | 0.010 |
Why?
|
| Immunosuppressive Agents | 3 | 2000 | 4213 | 0.010 |
Why?
|
| Hemagglutination Tests | 2 | 1974 | 76 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1974 | 812 | 0.010 |
Why?
|
| Fibrosarcoma | 3 | 1980 | 312 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1985 | 870 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 1995 | 1637 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1984 | 283 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1990 | 1962 | 0.010 |
Why?
|
| Vaccination | 1 | 1995 | 3431 | 0.010 |
Why?
|
| Rats, Inbred F344 | 2 | 1982 | 820 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 1985 | 1099 | 0.010 |
Why?
|
| Thymectomy | 2 | 1984 | 200 | 0.010 |
Why?
|
| Schistosoma mansoni | 1 | 1983 | 154 | 0.010 |
Why?
|
| Terminology as Topic | 2 | 1980 | 1536 | 0.010 |
Why?
|
| Binding Sites | 2 | 1989 | 6001 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1987 | 3051 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1985 | 740 | 0.010 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2002 | 78 | 0.010 |
Why?
|
| Goats | 1 | 1981 | 166 | 0.010 |
Why?
|
| Cryopreservation | 1 | 2006 | 727 | 0.010 |
Why?
|
| Radiation Chimera | 3 | 1978 | 216 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 788 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 2 | 1979 | 319 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14645 | 0.010 |
Why?
|
| Haplotypes | 1 | 1987 | 2726 | 0.010 |
Why?
|
| Immunoglobulin D | 1 | 1980 | 55 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1980 | 58 | 0.010 |
Why?
|
| Piperazines | 1 | 1991 | 2547 | 0.010 |
Why?
|
| Sarcoma, Experimental | 2 | 1977 | 116 | 0.010 |
Why?
|
| Amino Acids | 1 | 1986 | 1710 | 0.010 |
Why?
|
| HLA-DR1 Antigen | 1 | 1999 | 11 | 0.010 |
Why?
|
| Granulocytes | 1 | 2002 | 548 | 0.010 |
Why?
|
| Fibrosis | 2 | 1997 | 2073 | 0.010 |
Why?
|
| Rats, Inbred BUF | 1 | 1979 | 19 | 0.010 |
Why?
|
| Rats, Inbred ACI | 1 | 1979 | 34 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1979 | 139 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1999 | 130 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2000 | 105 | 0.010 |
Why?
|
| Birds | 1 | 1980 | 165 | 0.010 |
Why?
|
| Neurons | 1 | 1999 | 9521 | 0.010 |
Why?
|
| Transplantation, Homologous | 3 | 1980 | 4860 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 657 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1979 | 410 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2001 | 827 | 0.010 |
Why?
|
| Collagen | 2 | 1997 | 2617 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20137 | 0.010 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1998 | 40 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 1998 | 48 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1978 | 148 | 0.010 |
Why?
|
| Proline | 1 | 1980 | 453 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 1150 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1979 | 683 | 0.010 |
Why?
|
| Cattle | 2 | 1981 | 3801 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1623 | 0.010 |
Why?
|
| Crossing Over, Genetic | 2 | 1974 | 92 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5020 | 0.010 |
Why?
|
| Peripheral Nervous System | 1 | 1998 | 151 | 0.010 |
Why?
|
| Biological Transport | 1 | 2001 | 2080 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 2 | 1993 | 1610 | 0.010 |
Why?
|
| Sirolimus | 1 | 2003 | 1541 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1988 | 3405 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 1518 | 0.010 |
Why?
|
| Hemadsorption | 2 | 1973 | 7 | 0.010 |
Why?
|
| Stem Cells | 1 | 1988 | 3537 | 0.010 |
Why?
|
| Ascaris | 1 | 1975 | 26 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1986 | 548 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1975 | 138 | 0.010 |
Why?
|
| Lipids | 1 | 1986 | 3316 | 0.010 |
Why?
|
| Leucine | 1 | 1976 | 547 | 0.010 |
Why?
|
| Glutamine | 1 | 1978 | 575 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1852 | 0.010 |
Why?
|
| Proteus | 1 | 1974 | 11 | 0.010 |
Why?
|
| Age Factors | 1 | 1991 | 18386 | 0.010 |
Why?
|
| Bordetella pertussis | 1 | 1974 | 45 | 0.010 |
Why?
|
| Immunosorbents | 3 | 1979 | 21 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 36427 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 1995 | 166 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1975 | 551 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1998 | 1742 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2000 | 1349 | 0.010 |
Why?
|
| Proviruses | 1 | 1995 | 319 | 0.010 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1973 | 100 | 0.010 |
Why?
|
| Resins, Plant | 1 | 1972 | 20 | 0.010 |
Why?
|
| Plants | 1 | 1974 | 332 | 0.010 |
Why?
|
| Graft Rejection | 2 | 2003 | 4504 | 0.010 |
Why?
|
| Nylons | 1 | 1972 | 47 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1992 | 102 | 0.010 |
Why?
|
| Cell Extracts | 2 | 1986 | 134 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1979 | 2603 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 416 | 0.010 |
Why?
|
| Serotyping | 1 | 1973 | 330 | 0.010 |
Why?
|
| Glass | 1 | 1972 | 116 | 0.010 |
Why?
|
| Muscles | 1 | 1997 | 1576 | 0.010 |
Why?
|
| Hominidae | 1 | 1972 | 68 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2267 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1986 | 3445 | 0.010 |
Why?
|
| Chromosomes | 1 | 1974 | 579 | 0.010 |
Why?
|
| Chloroquine | 1 | 1992 | 276 | 0.010 |
Why?
|
| Sex Factors | 1 | 1984 | 10614 | 0.010 |
Why?
|
| Disease Progression | 2 | 1997 | 13616 | 0.010 |
Why?
|
| Solubility | 1 | 1972 | 1077 | 0.010 |
Why?
|
| Methylcholanthrene | 2 | 1980 | 30 | 0.010 |
Why?
|
| Papio | 1 | 1972 | 671 | 0.010 |
Why?
|
| Skin Transplantation | 2 | 1973 | 1097 | 0.010 |
Why?
|
| Esterases | 1 | 1990 | 89 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1990 | 216 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1997 | 1337 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1999 | 2916 | 0.010 |
Why?
|
| Primates | 1 | 1972 | 519 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1990 | 527 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1984 | 6612 | 0.000 |
Why?
|
| Uveitis | 1 | 1992 | 398 | 0.000 |
Why?
|
| Antigens, Viral | 2 | 1983 | 995 | 0.000 |
Why?
|
| Skin | 1 | 2001 | 4482 | 0.000 |
Why?
|
| Neutralization Tests | 1 | 1990 | 735 | 0.000 |
Why?
|
| Pedigree | 2 | 1973 | 4535 | 0.000 |
Why?
|
| Cholera Toxin | 1 | 1990 | 562 | 0.000 |
Why?
|
| Aging | 1 | 1986 | 8723 | 0.000 |
Why?
|
| Saliva | 1 | 1972 | 852 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1990 | 792 | 0.000 |
Why?
|
| Allergens | 1 | 1974 | 1435 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1972 | 1075 | 0.000 |
Why?
|
| Columbidae | 1 | 1985 | 40 | 0.000 |
Why?
|
| Temperature | 1 | 1972 | 2227 | 0.000 |
Why?
|
| Oxazolone | 1 | 1984 | 59 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1981 | 2469 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1504 | 0.000 |
Why?
|
| Genes, Recessive | 1 | 1986 | 625 | 0.000 |
Why?
|
| Alkylation | 1 | 1983 | 84 | 0.000 |
Why?
|
| Chemistry | 1 | 1983 | 325 | 0.000 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1974 | 1910 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1983 | 483 | 0.000 |
Why?
|
| Liposomes | 1 | 1986 | 786 | 0.000 |
Why?
|
| Epithelium | 1 | 1987 | 1604 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1982 | 860 | 0.000 |
Why?
|
| Rats, Inbred BN | 1 | 1981 | 229 | 0.000 |
Why?
|
| Disulfides | 1 | 1983 | 461 | 0.000 |
Why?
|
| Genes, Regulator | 1 | 1980 | 373 | 0.000 |
Why?
|
| Asthma | 1 | 1998 | 6268 | 0.000 |
Why?
|
| Enzymes | 1 | 1980 | 253 | 0.000 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 1977 | 65 | 0.000 |
Why?
|
| Poultry | 1 | 1977 | 79 | 0.000 |
Why?
|
| Palmitates | 1 | 1977 | 68 | 0.000 |
Why?
|
| Thymidine | 1 | 1977 | 294 | 0.000 |
Why?
|
| Mitogens | 1 | 1977 | 228 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1983 | 2221 | 0.000 |
Why?
|
| Listeriosis | 1 | 1977 | 146 | 0.000 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1980 | 540 | 0.000 |
Why?
|
| Listeria monocytogenes | 1 | 1977 | 245 | 0.000 |
Why?
|
| Hybridization, Genetic | 1 | 1975 | 102 | 0.000 |
Why?
|
| Autoradiography | 1 | 1975 | 723 | 0.000 |
Why?
|
| Graft vs Host Reaction | 1 | 1973 | 99 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1980 | 1531 | 0.000 |
Why?
|
| Syndrome | 1 | 1980 | 3270 | 0.000 |
Why?
|
| Trypan Blue | 1 | 1973 | 20 | 0.000 |
Why?
|
| Ferritins | 1 | 1976 | 600 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1980 | 2838 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1979 | 3594 | 0.000 |
Why?
|
| Middle Aged | 2 | 1973 | 223083 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1973 | 4277 | 0.000 |
Why?
|
| Child | 1 | 1973 | 80573 | 0.000 |
Why?
|
| Adolescent | 1 | 1973 | 88819 | 0.000 |
Why?
|
| Aged | 1 | 1973 | 171219 | 0.000 |
Why?
|
| Adult | 1 | 1973 | 223139 | 0.000 |
Why?
|